Bacterial Infections in End-Stage Liver Disease: Implications for Liver Transplantation
暂无分享,去创建一个
M. Senzolo | M. Gambato | G. Germani | A. Zanetto | A. Ferrarese | L. Sasset | S. Battistella | A. Cattelan | Filippo Pelizzaro | U. Cillo | P. Burra | F. P. Russo | Stefania Vio | Domenico Bassi
[1] MarkJ W McPhail,et al. Liver transplantation for acute-on-chronic liver failure. , 2024, The lancet. Gastroenterology & hepatology.
[2] Shivang Mehta,et al. Policy corner: Cholangitis exception update. , 2023, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[3] Chi-Chih Wang,et al. Risk factors for pre‐transplantation bacteremia in adults with end‐stage liver disease: Effects on outcomes of liver transplantation , 2023, Clinical transplantation.
[4] C. Féray,et al. Liver transplant selection criteria and outcomes in critically ill patients with ACLF , 2023, JHEP reports : innovation in hepatology.
[5] A. O'Brien,et al. Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe? , 2023, Hepatology communications.
[6] C. Hsiao,et al. Predictor of gram-negative bacteremia in cirrhotic patients with skin and soft-tissue infections , 2023, Medicine.
[7] T. Gustot,et al. Management of the acute on chronic liver failure in the intensive care unit. , 2023, Liver international : official journal of the International Association for the Study of the Liver.
[8] P. Angeli,et al. Impact of bacterial infections prior to liver transplantation on post-transplant outcomes in patients with cirrhosis , 2023, JHEP reports : innovation in hepatology.
[9] A. Duseja,et al. Burden, risk factors, and outcomes of multidrug-resistant bacterial colonisation at multiple sites in patients with cirrhosis , 2023, JHEP reports : innovation in hepatology.
[10] M. Papp,et al. EASL Clinical Practice Guidelines on acute-on-chronic liver failure. , 2023, Journal of hepatology.
[11] R. Bhanji,et al. Exception points for liver transplantation: A Canadian review. , 2022, Canadian liver journal.
[12] M. Merli,et al. Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections in Patients With Liver Cirrhosis. , 2022, Journal of clinical and experimental hepatology.
[13] M. Hogardt,et al. Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis. , 2022, Journal of hepatology.
[14] R. Jalan,et al. Cirrhosis-associated immune dysfunction , 2021, Nature Reviews Gastroenterology & Hepatology.
[15] Javier Fernández,et al. Management of bacterial and fungal infections in cirrhosis: The MDRO challenge. , 2021, Journal of hepatology.
[16] G. Szabo,et al. Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. , 2021, Journal of hepatology.
[17] S. Chokshi,et al. The multifactorial mechanisms of bacterial infection in decompensated cirrhosis. , 2021, Journal of hepatology.
[18] K. Reddy,et al. The Evolving Challenge of Infections in Cirrhosis. , 2021, The New England journal of medicine.
[19] R. Jalan,et al. 'Equity' and 'justice' for patients with acute-on chronic liver failure: A call to action. , 2021, Journal of hepatology.
[20] A. McCullough,et al. Trends and outcomes of infective endocarditis in cirrhosis: a propensity-matched national study , 2021, European journal of gastroenterology & hepatology.
[21] C. O’Farrelly,et al. Inflammatory processes in the liver: divergent roles in homeostasis and pathology , 2021, Cellular & Molecular Immunology.
[22] R. Moreau,et al. The Systemic Inflammation Hypothesis: Towards a New Paradigm of Acute Decompensation and Multiorgan Failure in Cirrhosis. , 2020, Journal of hepatology.
[23] N. Mahmud,et al. Patients with severe acute‐on‐chronic liver failure are disadvantaged by model for end‐stage liver disease‐based organ allocation policy , 2020, Alimentary pharmacology & therapeutics.
[24] A. Frigo,et al. Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection , 2020, Clinical chemistry and laboratory medicine.
[25] E. Seminari,et al. Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] M. Ison,et al. Pre‐ and post‐transplant bacterial infections in liver transplant recipients , 2019, Transplant infectious disease : an official journal of the Transplantation Society.
[27] P. Angeli,et al. Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation , 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[28] S. Abd-Elsalam,et al. Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt , 2019, Infection and drug resistance.
[29] Douglas A. Simonetto,et al. Management of Sepsis in Patients With Cirrhosis: Current Evidence and Practical Approach , 2019, Hepatology.
[30] K. Reddy,et al. Nosocomial Infections Are Frequent and Negatively Impact Outcomes in Hospitalized Patients With Cirrhosis. , 2019, The American journal of gastroenterology.
[31] H. Van Vlierberghe,et al. Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide. , 2019, Gastroenterology.
[32] M. Senzolo,et al. Outcome of critically ill cirrhotic patients admitted to the ICU: The role of ACLF. , 2019, Journal of hepatology.
[33] A. de Gottardi,et al. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe. , 2019, Journal of hepatology.
[34] J. Cadranel,et al. Infectious endocarditis in the case of cirrhosis: where do we stand? , 2018, European journal of gastroenterology & hepatology.
[35] J. Trebicka,et al. Corrigendum to "EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis" [J Hepatol 69 (2018) 406-460]. , 2018, Journal of hepatology.
[36] A. Lohse,et al. Stabilisation of acute‐on‐chronic liver failure patients before liver transplantation predicts post‐transplant survival , 2018, Alimentary pharmacology & therapeutics.
[37] R. Steadman,et al. Potentially inappropriate liver transplantation in the era of the "sickest first" policy - A search for the upper limits. , 2017, Journal of hepatology.
[38] S. Jaber,et al. Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3. , 2017, Journal of hepatology.
[39] R. Jalan,et al. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis , 2017, Gut.
[40] G. Boccia,et al. Bacterial meningitis complicating the course of liver cirrhosis , 2017, Infection.
[41] A. Burroughs,et al. Bacterial Infections Change Natural History of Cirrhosis Irrespective of Liver Disease Severity , 2017, The American Journal of Gastroenterology.
[42] Im-kyung Kim,et al. Impact of Pre-Transplant Bacterial Infections on Post-Operative Outcomes in Patients after Liver Transplantation. , 2017, Surgical infections.
[43] A. Cucchetti,et al. Impact of preoperative infection on outcome after liver transplantation , 2017, The British journal of surgery.
[44] Su Lin,et al. Serum interleukin-6 in the diagnosis of bacterial infection in cirrhotic patients , 2016, Medicine.
[45] Ming Chen,et al. The role of the neutrophil Fcγ receptor I (CD64) index in diagnosing spontaneous bacterial peritonitis in cirrhotic patients. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[46] V. Mazzaferro,et al. A Multistep, Consensus‐Based Approach to Organ Allocation in Liver Transplantation: Toward a “Blended Principle Model” , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[47] A. Burroughs,et al. C-reactive protein and bacterial infection in cirrhosis , 2014, Annals of gastroenterology.
[48] J. Vincent,et al. Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study , 2014, Liver international : official journal of the International Association for the Study of the Liver.
[49] R. Moreau,et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. , 2013, Gastroenterology.
[50] K. Reddy,et al. Second infections independently increase mortality in hospitalized patients With cirrhosis: the north american consortium for the study of end‐stage liver disease (NACSELD) experience , 2012, Hepatology.
[51] A. Burroughs,et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. , 2010, Gastroenterology.
[52] S. Erlinger,et al. European Association for the Study of the Liver , 2006 .